| Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance L Mashouri, H Yousefi, AR Aref, A Ahadi, F Molaei, SK Alahari Molecular cancer 18, 1-14, 2019 | 1100 | 2019 |
| Long noncoding RNAs and exosomal lncRNAs: classification, and mechanisms in breast cancer metastasis and drug resistance H Yousefi, M Maheronnaghsh, F Molaei, L Mashouri, A Reza Aref, ... Oncogene 39 (5), 953-974, 2020 | 177 | 2020 |
| Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action H Yousefi, L Mashouri, SC Okpechi, N Alahari, SK Alahari Biochemical pharmacology 183, 114296, 2021 | 114 | 2021 |
| Understanding the role of integrins in breast cancer invasion, metastasis, angiogenesis, and drug resistance H Yousefi, M Vatanmakanian, M Mahdiannasser, L Mashouri, NV Alahari, ... Oncogene 40 (6), 1043-1063, 2021 | 82 | 2021 |
| Hippo pathway: Regulation, deregulation and potential therapeutic targets in cancer S Mohajan, PK Jaiswal, M Vatanmakarian, H Yousefi, S Sankaralingam, ... Cancer letters 507, 112-123, 2021 | 69 | 2021 |
| Non-coding RNAs in cartilage development: an updated review E Razmara, A Bitaraf, H Yousefi, TH Nguyen, M Garshasbi, WC Cho, ... International journal of molecular sciences 20 (18), 4475, 2019 | 65 | 2019 |
| The roles of tumor-derived exosomes in altered differentiation, maturation and function of dendritic cells R Hosseini, L Asef-Kabiri, H Yousefi, H Sarvnaz, M Salehi, ME Akbari, ... Molecular cancer 20 (1), 83, 2021 | 58 | 2021 |
| Cancer exosomes and natural killer cells dysfunction: biological roles, clinical significance and implications for immunotherapy R Hosseini, H Sarvnaz, M Arabpour, SM Ramshe, L Asef-Kabiri, ... Molecular cancer 21 (1), 15, 2022 | 49 | 2022 |
| Vitamin D receptor (VDR) gene polymorphism and risk of rheumatoid arthritis (RA): systematic review and meta-analysis Z Bagheri-Hosseinabadi, D Imani, H Yousefi, M Abbasifard Clinical Rheumatology 39, 3555-3569, 2020 | 42 | 2020 |
| Non-coding RNAs underlying chemoresistance in gastric cancer A Poursheikhani, Z Bahmanpour, E Razmara, L Mashouri, M Taheri, ... Cellular oncology 43, 961-988, 2020 | 39 | 2020 |
| IL-6/IL-6R pathway is a therapeutic target in chemoresistant ovarian cancer H Yousefi, M Momeny, SH Ghaffari, N Parsanejad, A Poursheikhani, ... Tumori journal 105 (1), 84-91, 2019 | 39 | 2019 |
| Blockade of vascular endothelial growth factor receptors by tivozanib has potential anti-tumour effects on human glioblastoma cells M Momeny, F Moghaddaskho, NK Gortany, H Yousefi, Z Sabourinejad, ... Scientific Reports 7 (1), 44075, 2017 | 36 | 2017 |
| SARS-CoV infection crosstalk with human host cell noncoding-RNA machinery: An in-silico approach H Yousefi, A Poursheikhani, Z Bahmanpour, M Vatanmakanian, M Taheri, ... Biomedicine & Pharmacotherapy 130, 110548, 2020 | 35 | 2020 |
| Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells M Momeny, Z Sabourinejad, G Zarrinrad, F Moghaddaskho, H Eyvani, ... Scientific reports 7 (1), 45954, 2017 | 34 | 2017 |
| Blockade of nuclear factor-κB (NF-κB) pathway inhibits growth and induces apoptosis in chemoresistant ovarian carcinoma cells M Momeny, H Yousefi, H Eyvani, F Moghaddaskho, A Salehi, F Esmaeili, ... The international journal of biochemistry & cell biology 99, 1-9, 2018 | 33 | 2018 |
| Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cells M Momeny, G Zarrinrad, F Moghaddaskho, A Poursheikhani, ... Scientific Reports 7 (1), 4204, 2017 | 33 | 2017 |
| The ERBB receptor inhibitor dacomitinib suppresses proliferation and invasion of pancreatic ductal adenocarcinoma cells M Momeny, F Esmaeili, S Hamzehlou, H Yousefi, S Javadikooshesh, ... Cellular Oncology 42, 491-504, 2019 | 28 | 2019 |
| Docosahexaenoic acid reverses the promoting effects of breast tumor cell-derived exosomes on endothelial cell migration and angiogenesis P Ghaffari-Makhmalbaf, M Sayyad, K Pakravan, E Razmara, A Bitaraf, ... Life sciences 264, 118719, 2021 | 27 | 2021 |
| MTHFR gene polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis based on 16 studies Z Bagheri-Hosseinabadi, D Imani, H Yousefi, M Abbasifard Clinical rheumatology 39, 2267-2279, 2020 | 23 | 2020 |
| Ceritinib is a novel triple negative breast cancer therapeutic agent S Dong, H Yousefi, IV Savage, SC Okpechi, MK Wright, MD Matossian, ... Molecular cancer 21 (1), 138, 2022 | 20 | 2022 |
Majid MomenyTexas Medical Center在 uth.tmc.edu 的电子邮件经过验证
